News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
US FDA approves Bristol-Myers’ lung cancer drug
Pharmaceutical company Bristol-Myers Squibb received FDA approval for Augtyro, a drug developed to treat lung cancer. The approval comes after the drug, was successful in
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
Seattle-based company Sana Biotechnology (Sana) received FDA clearance for its Investigational New Drug application aimed at treating “patients with multiple B-cell mediated autoimmune diseases,” according
Alpine Immune Sciences raising $150M through public offering
Alpine Immune Sciences Inc., a biotech company based in Seattle, has raised $150 million through underwritten public funding. According to Alpine, the new funding brings
BioLife Solutions raises $10.4M through private placement
BioLife Solutions Inc., a biological material storage business based in Bothell, Washington, received $10.4 million in funding from Casdin Capital, an investment firm based out
Novartis’ $3.2B Chinook Buy Pays Off with Promising Phase III IgAN Data
Seattle-based Chinook Therapeutics, purchased earlier this year by Swiss pharmaceutical company Novartis, announced a successful Phase III ALIGN study with its drug, atrasentan. Atrasentan, intended
Gut microbiome startup Viome buys digital wellness startup Naring Health
Bellevue-based biotech company Viome Life Sciences acquired Naring Health, a startup company specializing in “personalized nutrition.” While specific details have not been disclosed, Viome will
Selkirk Pharma raises $24M in seed funding
Selkirk Pharma, a Spokane-based startup, raised $24.1 million to support its development of sterile therapeutics. The funding, which came from unnamed investors, brings Selkirk’s total
Biotech combo to make Bothell its new home
Pennsylvania-based biotech company Immunome has announced it will be relocating to Seattle following its merger with local firm Morphimmune. The partners will reside in the
Aurion doses first patients in US Phase 1/2 clinical trial
Seattle-based company Aurion Biotech announced that a subject in its Phase 1/2 clinical trial was the first to receive a dose of its corneal endothelial
Seattle ranks No. 1 in new report measuring U.S. cities on highly valued tech skills
A report from Cities on the Tech Frontier announced Seattle as the American city with the best technology talent, placing it above hubs like Silicon
Lumen Bioscience secures DOD funding for infection treatment
Seattle-based biotech company Lumen Bioscience received $16.2 million from the U.S. Department of Defense to support the development of its C. difficile treatment. The award
Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy
The European Commission granted pharmaceutical giant Pfizer unconditional EU antitrust approval for its acquisition of Bothell-based biotech company Seagen. The acquisition, announced in March of